Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001758363-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | May 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
15,000
Total Value
$1,070,507.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 1, 2026 | Sale | 5,300 | $69.54 | $368,562.00 | 622,240 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 3,600 | $70.77 | $254,772.00 | 618,640 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 1,000 | $71.76 | $71,760.00 | 617,640 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 3,100 | $73.14 | $226,734.00 | 614,540 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 1,700 | $74.23 | $126,191.00 | 612,840 | Direct | โ | View Details | |
Director | Common Stock | โ | May 1, 2026 | Sale | 300 | $74.96 | $22,488.00 | 612,540 | Direct | โ | View Details |